HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Semelka, R. C. Articles by Helmberger, T. K. G. Search for Related Content PubMed PubMed Citation Articles by Semelka, R. C. Articles by Helmberger, T. K. G.

Contrast Agents for MR Imaging of the Liver¹

¹ From the Department of Radiology, University of North Carolina School of Medicine, CB 7510, Chapel Hill, NC 27599-7510 (R.C.S.); and the Department of Radiology, Klinikum Grosshadern, Munich, Germany (T.K.G.H.). Received June 22, 1999; revision requested August 6; final revision received November 15; accepted December 6, 1999. Address correspondence to R.C.S. (e-mail: richsem@med.unc.edu).

A variety of different categories of contrast agents, and within each category a number of individual agents, are currently available for clinical use in magnetic resonance (MR) imaging of the liver. In this review, the use of nonspecific extracellular gadolinium chelates, reticuloendothelial system–specific iron oxide particulate agents, hepatocyte-selective agents, and combined perfusion and hepatocyte-selective agents are described. Most clinical experience is with nonspecific extracellular gadolinium chelates. The relatively low cost, safety, good patient tolerance, and ability to help detect and characterize a wide range of liver diseases have rendered gadolinium chelates as commonly used agents. Reticuloendothelial system–specific agents improve lesion detection by decreasing the signal intensity of background liver on T2-weighted MR images, which increases the conspicuity of focal hepatic lesions with negligible reticuloendothelial cells (eg, metastases). Hepatocyte-selective agents increase the signal intensity of background liver on T1-weighted images, which increases the conspicuity of focal lesions that do not contain hepatocytes (eg, metastases). The clinical application of the different categories of contrast agents, techniques for their administration, sequences to be used, and appearances of common entities on contrast agent–enhanced studies are described.

Index terms: Liver, MR, 761.1214 • Liver neoplasms, 761.3198, 761.32, 761.33 • Magnetic resonance (MR), contrast media, 761.12143 • State of the Art

This article has been cited by other articles:

				S. N. Gandhi, M. A. Brown, J. G. Wong, D. A. Aguirre, and C. B. Sirlin MR Contrast Agents for Liver Imaging: What, When, How RadioGraphics, November 1, 2006; 26(6): 1621 - 1636. [Abstract] [Full Text] [PDF]

				F. H. Miller, N. J. Rini, and A. L. Keppke MRI of Adenocarcinoma of the Pancreas Am. J. Roentgenol., October 1, 2006; 187(4): W365 - W374. [Abstract] [Full Text] [PDF]

				M.-J. Kim, J. H. Kim, J. Y. Choi, S. H. Park, J.-J. Chung, K. W. Kim, and D. G. Mitchell Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. Am. J. Roentgenol., September 1, 2006; 187(3): W255 - W266. [Abstract] [Full Text] [PDF]

				M.-A. Weber, H. Krakowski-Roosen, S. Delorme, H. Renk, M. Krix, J. Millies, R. Kinscherf, A. Kunkele, H.-U. Kauczor, and W. Hildebrandt Relationship of skeletal muscle perfusion measured by contrast-enhanced ultrasonography to histologic microvascular density. J. Ultrasound Med., May 1, 2006; 25(5): 583 - 591. [Abstract] [Full Text] [PDF]

				M. Krix, M.-A. Weber, H. Krakowski-Roosen, H. B. Huttner, S. Delorme, H.-U. Kauczor, and W. Hildebrandt Assessment of Skeletal Muscle Perfusion Using Contrast-Enhanced Ultrasonography J. Ultrasound Med., April 1, 2005; 24(4): 431 - 441. [Abstract] [Full Text] [PDF]

				A. Huppertz, S. Haraida, A. Kraus, C. J. Zech, J. Scheidler, J. Breuer, T. K. Helmberger, and M. F. Reiser Enhancement of Focal Liver Lesions at Gadoxetic Acid-enhanced MR Imaging: Correlation with Histopathologic Findings and Spiral CT--Initial Observations Radiology, February 1, 2005; 234(2): 468 - 478. [Abstract] [Full Text] [PDF]

				M.-S. Park, K. W. Kim, J.-S. Yu, M.-J. Kim, K. W. Kim, J. S. Lim, E.-S. Cho, D.-S. Yoon, T. K. Kim, S. I. Lee, et al. Early Biliary Complications of Laparoscopic Cholecystectomy: Evaluation on T2-Weighted MR Cholangiography in Conjunction with Mangafodipir Trisodium-Enhanced T1-Weighted MR Cholangiography Am. J. Roentgenol., December 1, 2004; 183(6): 1559 - 1566. [Abstract] [Full Text] [PDF]

				R Razzaq, MBchB, MRCP, FRCR and S A Sukumar Imaging of the jaundiced adult Imaging, September 1, 2004; 16(4): 287 - 300. [Abstract] [Full Text] [PDF]

				D. V. Sahani, S. P. Kalva, K. K. Tanabe, S. M. Hayat, M. J. O'Neill, E. F. Halpern, S. Saini, and P. R. Mueller Intraoperative US in Patients Undergoing Surgery for Liver Neoplasms: Comparison with MR Imaging Radiology, September 1, 2004; 232(3): 810 - 814. [Abstract] [Full Text] [PDF]

				A. Huppertz, T. Balzer, A. Blakeborough, J. Breuer, A. Giovagnoni, G. Heinz-Peer, M. Laniado, R. M. Manfredi, D. G. Mathieu, D. Mueller, et al. Improved Detection of Focal Liver Lesions at MR Imaging: Multicenter Comparison of Gadoxetic Acid-enhanced MR Images with Intraoperative Findings Radiology, January 1, 2004; 230(1): 266 - 275. [Abstract] [Full Text] [PDF]

				C. M. Pastor, C. Planchamp, S. Pochon, V. Lorusso, X. Montet, J. Mayer, F. Terrier, and J.-P. Vallee Kinetics of Gadobenate Dimeglumine in Isolated Perfused Rat Liver: MR Imaging Evaluation Radiology, October 1, 2003; 229(1): 119 - 125. [Abstract] [Full Text] [PDF]

				M.-J. Kim, J. H. Kim, J.-J. Chung, M. S. Park, J. S. Lim, and Y. T. Oh Focal Hepatic Lesions: Detection and Characterization with Combination Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging Radiology, September 1, 2003; 228(3): 719 - 726. [Abstract] [Full Text] [PDF]

				J. A. Frank, B. R. Miller, A. S. Arbab, H. A. Zywicke, E. K. Jordan, B. K. Lewis, L. H. Bryant Jr, and J. W. M. Bulte Clinically Applicable Labeling of Mammalian and Stem Cells by Combining Superparamagnetic Iron Oxides and Transfection Agents Radiology, August 1, 2003; 228(2): 480 - 487. [Abstract] [Full Text] [PDF]

				K. W. Kim, M.-S. Park, J.-S. Yu, J. P. Chung, Y. H. Ryu, S. I. Lee, K. S. Lee, S.-W. Yoon, and K.-H. Lee Acute Cholecystitis at T2-weighted and Manganese-enhanced T1-weighted MR Cholangiography: Preliminary Study Radiology, May 1, 2003; 227(2): 580 - 584. [Abstract] [Full Text] [PDF]

				A. Ba-Ssalamah, W. Schima, M. T. Schmook, K. F. Linnau, N. Schibany, T. Helbich, P. Reimer, F. Laengle, F. Wrba, A. Kurtaran, et al. Atypical Focal Nodular Hyperplasia of the Liver: Imaging Features of Nonspecific and Liver-Specific MR Contrast Agents Am. J. Roentgenol., December 1, 2002; 179(6): 1447 - 1456. [Abstract] [Full Text] [PDF]

				Y. Itai, T. Irie, and R. C. Semelka Metastatic Liver Tumor: Circumferential versus Wedge-shaped Perilesional Enhancement and Quantitative Image and Pathologic Correlation Dr Semelka responds: Radiology, April 1, 2001; 219(1): 298 - 300. [Full Text]